# A Study To Determine The Efficacy And Safety Of Tigecycline Compared With Imipenem/Cliastatin to Treat Complicated Intra-Abdominal Infection

> **NCT01721408** · PHASE4 · COMPLETED · sponsor: **Pfizer** · enrollment: 470 (actual)

## Conditions studied

- Intra-abdominal Infection

## Interventions

- **DRUG:** Tigecycline
- **DRUG:** Imipenem/cilastatin

## Key facts

- **NCT ID:** NCT01721408
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 470 (ACTUAL)
- **Last updated:** 2018-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01721408

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01721408, "A Study To Determine The Efficacy And Safety Of Tigecycline Compared With Imipenem/Cliastatin to Treat Complicated Intra-Abdominal Infection". Retrieved via AI Analytics 2026-09-28 from https://api.ai-analytics.org/clinical/NCT01721408. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*